Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 119711
Published online Aug 19, 2026. doi: 10.5498/wjp.119711
Published online Aug 19, 2026. doi: 10.5498/wjp.119711
Table 1 Baseline sociodemographic and obstetric characteristics of the study population
| Variable | Total (n = 220) | mean ± SD/n (%) |
| Maternal age (years) | 220 | 29.8 ± 4.6 |
| Age ≥ 35 years | 220 | 46 (20.9) |
| Primiparity | 220 | 102 (46.4) |
| Multiparity | 220 | 118 (53.6) |
| Pre-pregnancy BMI (kg/m2) | 220 | 26.4 ± 3.8 |
| BMI ≥ 30 kg/m2 | 220 | 48 (21.8) |
| Gestational age at delivery (weeks) | 220 | 37.9 ± 2.1 |
| Preterm delivery (< 37 weeks) | 220 | 44 (20.0) |
| Vaginal delivery | 220 | 134 (60.9) |
| Cesarean delivery | 220 | 86 (39.1) |
| Neonatal birth weight (g) | 220 | 3025 ± 485 |
| NICU admission | 220 | 36 (16.4) |
Table 2 Comparison of baseline characteristics between growth hormone deficiency and normotensive cohorts, n (%)/mean ± SD
| Variable | GHD (n = 110) | Controls (n = 110) | P value |
| Maternal age (years) | 30.2 ± 4.7 | 29.4 ± 4.5 | 0.18 |
| BMI (kg/m2) | 27.8 ± 4.1 | 25.0 ± 3.2 | < 0.001 |
| Primiparity | 58 (52.7) | 44 (40.0) | 0.04 |
| Preterm delivery | 30 (27.3) | 14 (12.7) | 0.006 |
| Cesarean delivery | 52 (47.3) | 34 (30.9) | 0.01 |
| NICU admission | 26 (23.6) | 10 (9.1) | 0.003 |
Table 3 Prevalence of postpartum anxiety and depression by growth hormone deficiency status, n (%)
| Outcome | GHD (n = 110) | Controls (n = 110) | P value |
| Postpartum anxiety | 42 (38.2) | 20 (18.2) | < 0.001 |
| No anxiety | 68 (61.8) | 90 (81.8) | - |
| Postpartum depression | 38 (34.5) | 17 (15.5) | < 0.001 |
| No depression | 72 (65.5) | 93 (84.5) | - |
Table 4 Crude odds ratios for postpartum anxiety and depression associated with gestational hypertensive disorder
| Outcome | Crude OR | 95%CI | P value |
| Postpartum anxiety | 2.78 | 1.51-5.12 | 0.001 |
| Postpartum depression | 2.86 | 1.49-5.49 | 0.001 |
Table 5 Adjusted odds ratios for postpartum anxiety and depression associated with gestational hypertensive disorder
| Outcome | Adjusted OR | 95%CI | P value |
| Postpartum anxiety | 2.71 | 1.45-5.05 | 0.002 |
| Postpartum depression | 2.89 | 1.52-5.48 | 0.001 |
Table 6 Distribution of supportive care exposure among women with gestational hypertensive disorder (n = 110)
| Supportive care status | n (%) |
| Received supportive care | 58 (52.7) |
| Standard postnatal care | 52 (47.3) |
Table 7 Postpartum anxiety and depression by supportive care status in the gestational hypertensive disorder cohort, n (%)
| Outcome | Supportive care (n = 58) | Standard care (n = 52) | P value |
| Postpartum anxiety | 16 (27.6) | 26 (50.0) | 0.01 |
| Postpartum depression | 15 (25.9) | 23 (44.2) | 0.02 |
| No anxiety or depression | 27 (46.5) | 13 (25.0) | 0.01 |
Table 8 Adjusted odds ratios for postpartum anxiety and depression associated with supportive care exposure
| Outcome | Adjusted OR | 95%CI | P value |
| Postpartum anxiety | 0.42 | 0.21-0.83 | 0.01 |
| Postpartum depression | 0.39 | 0.19-0.81 | 0.01 |
- Citation: Chen CR, Gao YL, Kang LP, Wu BY. Risk of postpartum anxiety and depression in women with a history of gestational hypertensive disorders. World J Psychiatry 2026; 16(8): 119711
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/119711.htm
- DOI: https://dx.doi.org/10.5498/wjp.119711